CIK 0002007919 · <br>Emerging growth company
Inhibrx Biosciences, Inc.
Sign in to watch- Ticker
- INBX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990613523
- Phone
- (858) 795-4220
- Business address
- 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $6,347,357
- in 7 filings
- Open-market sales, last 90 days
- $279,010
- in 2 filings
Net +$6,068,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-14 | Lappe Mark Chief Executive Officer | Purchase | +2,470 | $84.07 | $208K | 743,018 |
| 2026-10-14 | Lappe Mark Chief Executive Officer | Purchase | +2,470 | $85.00 | $210K | 745,488 |
| 2026-10-14 | Lappe Mark Chief Executive Officer | Purchase | +100 | $85.76 | $9K | 745,588 |
| 2026-10-14 | Lappe Mark Chief Executive Officer | Purchase | +2,449 | $84.07 | $206K | 167,449 |
| 2026-10-14 | Lappe Mark Chief Executive Officer | Purchase | +2,451 | $85.00 | $208K | 169,900 |
| 2026-10-14 | Lappe Mark Chief Executive Officer | Purchase | +100 | $85.76 | $9K | 170,000 |
| 2026-09-28 | Lappe Mark Chief Executive Officer | Purchase | +1,500 | $98.88 | $148K | 737,548 |
| 2026-09-28 | Lappe Mark Chief Executive Officer | Purchase | +3,000 | $101.70 | $305K | 740,548 |
| 2026-09-25 | Lappe Mark Chief Executive Officer | Purchase | +3,324 | $98.87 | $329K | 733,872 |
| 2026-09-25 | Lappe Mark Chief Executive Officer | Purchase | +2,176 | $99.60 | $217K | 736,048 |
| 2026-09-23 | Kayyem Jon Faiz Director | Purchase | +5,000 | $100.00 | $500K | 434,360 |
| 2026-09-16 | Kayyem Jon Faiz Director | Purchase | +5,000 | $100.00 | $500K | 429,360 |
| 2026-09-15 | MANHARD KIMBERLY Director | Sale | −500 | $105.05 | $53K | 7,500 |
| 2026-09-14 | MANHARD KIMBERLY Director | Sale | −500 | $110.26 | $55K | 8,000 |
| 2026-09-11 | MANHARD KIMBERLY Director | Sale | −500 | $111.78 | $56K | 8,500 |
| 2026-09-09 | MANHARD KIMBERLY Director | Sale | −500 | $115.80 | $58K | 9,000 |
| 2026-09-08 | MANHARD KIMBERLY Director | Sale | −500 | $115.14 | $58K | 9,500 |
| 2026-09-08 | Kayyem Jon Faiz Director | Purchase | +5,000 | $113.52 | $568K | 424,360 |
| 2026-09-08 | Lappe Mark Chief Executive Officer | Purchase | +5,895 | $99.29 | $585K | 711,443 |
| 2026-09-08 | Lappe Mark Chief Executive Officer | Purchase | +6,605 | $100.64 | $665K | 718,048 |
Page 1 of 5 · 98 trades